BlueMTech Launches Post-Payment Service for Pharmaceutical Distribution

## Innovation for Medical Institutions! BlueMtech Fully Introduces Buy Now Pay Later (BNPL) Service to 'Bluepharm Korea' BlueMtech, which operates the pharmaceutical e-commerce platform 'Bluepharm Korea,' has officially launched a Buy Now Pay Later (BNPL) service exclusively for hospitals and clinics through collaboration with fintech startup Finoverse Lab, bringing a fresh wave of change to the pharmaceutical procurement environment for medical institutions. The newly introduced BNPL service is, literally, an innovative payment method that allows users to 'buy now and pay later.' While similar to existing credit card services, it possesses several crucial distinguishing features. Its greatest appeal lies in its freedom from credit card limits and the absence of separate fees for the buyer. Particularly, considering the nature of pharmaceuticals, which involve large payment volumes per transaction, upfront payments for bulk purchases on e-commerce platforms have often placed a significant financial burden on medical institutions. Bluepharm Korea's BNPL service addresses this challenge by offering a flexible payment method, allowing payments to be made within up to two months after purchase. This is expected to enhance the convenience and efficiency of pharmaceutical procurement for medical institutions by securing cash flow and effectively reducing financial burdens. A BlueMtech official stated, "The introduction of this BNPL service will significantly alleviate the financial burden on member hospitals and clinics, while also serving as a crucial catalyst for accelerating digital innovation in the pharmaceutical distribution market." They added, "We aspire to contribute to creating a smarter and more efficient medical environment through the development of various services in the future." Finoverse Lab, the collaborating partner, is a fintech startup established in 2020, recognized for its expertise in the B2B BNPL sector through the successful operation of its 'Paymonz' service. The synergy between BlueMtech and Finoverse Lab represents a significant example of the convergence of digital transformation in the medical field and smart financial solutions, and is expected to positively impact the future development of the pharmaceutical distribution market.